Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Egypt J Immunol ; 31(3): 161-169, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38996074

ABSTRACT

Pregnancy results in an increase in immune cells, especially monocytes, which enhances the innate immune system. The increase of inflammatory cytokines in pregnant women's amniotic fluid, can cause uterine contraction, is linked to preterm labor. These inflammatory responses are controlled by Toll-like receptors (TLRs), which are largely expressed on neutrophils and monocytes. This study aimed to determine the role of neutrophils and monocyte subsets, as well as their expression of TLR-2 and TLR-4 in women with preterm and full-term delivery. The study involved a total of 74 women, comprising of 29 preterm labor, 25 full-term labor, and 20 non-pregnant women. The distribution of three monocyte subsets, namely (CD14++CD16-), (CD14+CD16+), and (CD14-/dim CD16++) was measured. Also, the expression of TLR2 and TLR4 in monocytes and neutrophils was analyzed using flow cytometry. Non-classical monocytes and intermediate monocytes were significantly higher in the preterm group than the control and full-term groups (p=0.041, p=0.043, and p=0.004, p= 0.049, respectively). Women in the preterm group showed significantly TLR2 expression on nonclassical monocytes compared to the control and full-term groups (p=0.002, and p=0.010, respectively). Also, preterm group expression of TLR4 was significantly higher in classical monocytes and nonclassical monocytes in comparison to the control group (p=0.019, and p≤0.0001, respectively). Besides, TLR4 expression was significantly up regulated in the preterm group compared to full-term in non-classical monocyte subset (p < 0.0001). Moreover, the expression of TLR-4 in neutrophils from the preterm group was statistically higher than expression from the full-term labor and control groups (p < .0001 for both). Such findings highlight the important role of monocyte subsets and neutrophils in activating the innate immune system and initiating strong pro-inflammatory responses that induce preterm labor. Additionally, TLR4 and TLR2 expressions on non-classical monocytes may be used as a marker to assess the probability of preterm labor.


Subject(s)
Monocytes , Neutrophils , Toll-Like Receptor 2 , Toll-Like Receptor 4 , Humans , Female , Toll-Like Receptor 2/metabolism , Toll-Like Receptor 4/metabolism , Pregnancy , Neutrophils/immunology , Neutrophils/metabolism , Monocytes/immunology , Monocytes/metabolism , Adult , Premature Birth/immunology , Term Birth/immunology , Obstetric Labor, Premature/immunology , Obstetric Labor, Premature/metabolism , Young Adult , Lipopolysaccharide Receptors/metabolism
2.
Cytokine Growth Factor Rev ; 78: 50-63, 2024 Aug.
Article in English | MEDLINE | ID: mdl-39048393

ABSTRACT

Preterm birth is a major public health concern, requiring a deeper understanding of its underlying inflammatory mechanisms and to develop effective therapeutic strategies. This review explores the complex interaction between inflammation and preterm labor, highlighting the pivotal role of the dysregulation of inflammation in triggering premature delivery. The immunological environment of pregnancy, characterized by a fragile balance of immune tolerance and resistance, is disrupted in preterm labor, leading to a pathological inflammatory response. Feto-maternal infections, among other pro-inflammatory stimuli, trigger the activation of toll-like receptors and the production of pro-inflammatory mediators, promoting uterine contractility and cervical ripening. Emerging anti-inflammatory therapeutics offer promising approaches for the prevention of preterm birth by targeting key inflammatory pathways. From TLR-4 antagonists to chemokine and interleukin receptor antagonists, these interventions aim to modulate the inflammatory environment and prevent adverse pregnancy outcomes. In conclusion, a comprehensive understanding of the inflammatory mechanisms leading to preterm labor is crucial for the development of targeted interventions in hope of reducing the incidence of preterm birth and improving neonatal health outcomes.


Subject(s)
Anti-Inflammatory Agents , Inflammation , Obstetric Labor, Premature , Humans , Pregnancy , Female , Obstetric Labor, Premature/immunology , Inflammation/immunology , Anti-Inflammatory Agents/therapeutic use , Premature Birth/immunology , Premature Birth/prevention & control , Animals , Infant, Newborn
3.
BMC Pregnancy Childbirth ; 24(1): 498, 2024 Jul 24.
Article in English | MEDLINE | ID: mdl-39048938

ABSTRACT

BACKGROUND: SARS-CoV-2 infection in pregnant women during the third trimester resulted in overall adverse pregnancy outcomes compared to non-infected controls and a unique humoral and cellular response at delivery. In this study we aimed to assess the impact of SARS-CoV-2 infection on maternal/neonatal peripartum outcomes andimmunological profiles. METHOD: In this study, we recruited 304 SARS-CoV-2 infected pregnant women and 910 SARS-CoV-2 non-infected pregnant women who were admitted for delivery. Peripartum and neonates' outcomes response to SARS-CoV-2 infection were analyzed. Furthermore, we characterized the antibody and cytokines profile in SARS-CoV-2 infected maternal blood (MB) and cord blood (CB). We also assessed routine laboratory tests and liver function tests in MB before labor. Unpaired T test, Mann-Whitney test and Spearman test were used to analyze the data. RESULTS: SARS-CoV-2 infected pregnant women were significantly associated with increased risk of adverse pregnancy outcomes, including preterm labor (13.8% vs. 9.5%, p = 0.033) and meconium-stained amniotic fluid (8.9% vs. 5.5%, p = 0.039). The risk of low birth weight (< 2500 g) (10.5% vs. 6.5%, p = 0.021) and Apgar score < 8 at 1-minute (9.2% vs. 5.8%, p = 0.049) significantly increased in newborns from COVID-19 positive mothers than their counterparts. Our results showed that antibodies were increased in adverse-outcome SARS-CoV-2 infected mothers and their neonates, and abnormal proportion of immune cells were detected in SARS-CoV-2 infected mothers. While the immune response showed no difference between adverse-outcome infected pregnant women and normal-outcome infected pregnant women. Thus, SARS-CoV-2 infection during the third trimester of pregnancy induced a unique humoral and cellular response at delivery. CONCLUSION: SARS-CoV-2 infection closer to delivery could incline to adverse pregnancy outcomes. Therefore, the utmost care is required for SARS-CoV-2 infected pregnant women and their newborns. TRIAL REGISTRATION: The study protocol was approved by the Institutional Review Board of the First Hospital of Jilin University with the approval code number 23K170-001, and informed consent was obtained from all enrolled patients prior to sample collection.


Subject(s)
COVID-19 , Pregnancy Complications, Infectious , Pregnancy Outcome , Pregnancy Trimester, Third , SARS-CoV-2 , Humans , Pregnancy , Female , COVID-19/immunology , Pregnancy Complications, Infectious/immunology , Pregnancy Trimester, Third/immunology , Adult , Infant, Newborn , SARS-CoV-2/immunology , Fetal Blood/immunology , Peripartum Period/immunology , Antibodies, Viral/blood , Cytokines/blood , Obstetric Labor, Premature/immunology
4.
Front Immunol ; 15: 1416162, 2024.
Article in English | MEDLINE | ID: mdl-38895127

ABSTRACT

Introduction: IL6 signaling plays an important role in triggering labor and IL6 is an established biomarker of intrauterine infection/inflammation (IUI) driven preterm labor (PTL). The biology of IL6 during IUI at the maternal-fetal interface was investigated in samples from human subjects and non-human primates (NHP). Methods: Pregnant women with histologic chorioamnionitis diagnosed by placenta histology were recruited (n=28 term, n=43 for preterm pregnancies from 26-36 completed weeks of gestation). IUI was induced in Rhesus macaque by intraamniotic injection of lipopolysachharide (LPS, n=23). IL1 signaling was blocked using Anakinra (human IL-1 receptor antagonist, n=13), and Tumor necrosis factor (TNF) signaling was blocked by anti TNF-antibody (Adalimumab n=14). The blockers were given before LPS. All animals including controls (intraamniotic injection of saline n=27), were delivered 16h after LPS/saline exposure at about 80% gestation. Results: IUI induced a robust expression of IL6 mRNAs in the fetal membranes (chorion-amnion-decidua tissue) both in humans (term and preterm) and NHP. The major sources of IL6 mRNA expression were the amnion mesenchymal cells (AMC) and decidua stroma cells. Additionally, during IUI in the NHP, ADAM17 (a protease that cleaves membrane bound IL6 receptor (IL6R) to release a soluble form) and IL6R mRNA increased in the fetal membranes, and the ratio of IL6 and soluble forms of IL6R, gp130 increased in the amniotic fluid signifying upregulation of IL6 trans-signaling. Both IL1 and TNF blockade suppressed LPS-induced IL6 mRNAs in the AMC and variably decreased elements of IL6 trans-signaling. Discussion: These data suggest that IL1 and TNF blockers may be useful anti-inflammatory agents via suppression of IL6 signaling at the maternal-fetal interface.


Subject(s)
Interleukin-6 , Macaca mulatta , Signal Transduction , Tumor Necrosis Factor-alpha , Female , Pregnancy , Humans , Animals , Interleukin-6/metabolism , Tumor Necrosis Factor-alpha/metabolism , Chorioamnionitis/immunology , Chorioamnionitis/metabolism , Chorioamnionitis/veterinary , Lipopolysaccharides/immunology , Interleukin-1/metabolism , Adult , Obstetric Labor, Premature/immunology , Obstetric Labor, Premature/metabolism , Inflammation/immunology , Inflammation/metabolism , Interleukin 1 Receptor Antagonist Protein/metabolism , Interleukin 1 Receptor Antagonist Protein/pharmacology , Placenta/metabolism , Placenta/immunology
5.
J Reprod Immunol ; 164: 104278, 2024 Aug.
Article in English | MEDLINE | ID: mdl-38901109

ABSTRACT

The objective of this study was to investigate the immune mechanisms involved in preterm labor (PTL), preterm prelabor rupture of the membranes (PPROM), and normal pregnancies. The second objective was to explore immune profiles in PTL for association with early ( < 34 gestational weeks (gw)) or instant ( < 48 h) delivery. This prospective observational multi-center study included women with singleton pregnancies with PTL (n = 80) or PPROM (n = 40) before 34 gw, women with normal pregnancies scheduled for antenatal visits (n = 44), and women with normal pregnancies in active labor at term (n = 40). Plasma samples obtained at admission were analyzed for cytokine and chemokine quantification using a multiplex bead assay in order to compare the immune profiles between PTL, PPROM, and normal pregnancies. In PTL, CXCL1 and CCL17 were significantly higher compared to gestational age-matched women at antenatal visits, whereas for PPROM, CXCL1 and IL-6 were increased. Women in term labor had a more pronounced inflammatory pattern with higher levels of CXCL1, CXCL8, and IL-6 compared with PTL (p = 0.007, 0.003, and 0.013, respectively), as well as higher levels of CCL17, CXCL1 and IL-6 (all p < 0.001) compared with the women at antenatal visits. In PTL, CXCL8 was higher in women with delivery before 34 gw, whereas CXCL8, GM-CSF, and IL-6 were significantly higher in women with delivery within 48 h. To conclude, PTL and PPROM were associated with a complex pattern of inflammation, both involving Th17 (CXCL1) responses. Although further studies are needed, CXCL8, GM-CSF, and IL-6 may be potential candidates for predicting preterm birth in PTL.


Subject(s)
Fetal Membranes, Premature Rupture , Obstetric Labor, Premature , Humans , Female , Pregnancy , Fetal Membranes, Premature Rupture/blood , Fetal Membranes, Premature Rupture/immunology , Adult , Obstetric Labor, Premature/immunology , Obstetric Labor, Premature/blood , Obstetric Labor, Premature/diagnosis , Prospective Studies , Cytokines/blood , Chemokines/blood , Interleukin-6/blood , Gestational Age , Chemokine CXCL1/blood , Chemokine CXCL1/metabolism , Chemokine CCL17
6.
Femina ; 37(9): 499-503, set. 2009.
Article in Portuguese | LILACS | ID: lil-539336

ABSTRACT

O parto pré-termo é uma das grandes intercorrências obstétricas, sendo a maior causa de morbidade e mortalidade perinatal. Dentre os diferentes fatores envolvidos no seu desencadeamento, a infecção intra-amniótica parece representar um papel central. As infecções desencadeiam resposta inflamatória nos tecidos materno e fetal, mediada pela produção de citocinas inflamatórias. As citocinas induzem a liberação de prostaglandinas, aumentando a contratilidade uterina, favorecendo a rotura das membranas fetais, a modificação e dilatação da cérvice e, finalmente, o parto pré-termo. A síntese de citocinas depende de controle genético. Diversos polimorfismos relacionados a genes humanos codificadores de citocinas são reconhecidos e associados a fenótipos de alta, média e baixa produção desses fatores. Assim sendo, a relação entre determinados genótipos e a ocorrência e/ou características de diferentes patologias tem sido investigada. Este tipo de abordagem pode contribuir para o conhecimento da patogenia, permitindo o reconhecimento de parâmetros preditivos e a definição de novas estratégias terapêuticas.


Preterm birth is a major obstetric incident and one of the main causes of perinatal mortality and morbidity. Among the different factors involved in its unleashing, intra-amniotic infection seems to play a central role. The infections unleash inflammatory response in both maternal and fetal tissues, mediated by the production of inflammatory cytokines. They also lead to liberation of prostaglandin, which increases myometrial contractility, favoring the rupture of fetal membrane, alteration and dilation of the cervix and, finally, preterm birth. The production of cytokines depends on genetic control. Many polymorphisms related to human genes that codify cytokines are recognized and associated with phenotypes of high, medium and low production of such factors. Thus, the relation between certain genotypes and the occurrence and/or characteristics of several pathologies has been the focus of investigations. This approach may contribute with a better understanding of the pathogenesis, allowing the identification of predictive parameters and the establishment of new intervention strategies.


Subject(s)
Female , Pregnancy , Cytokines/genetics , Pregnancy Complications, Infectious/metabolism , Amniotic Fluid/metabolism , Amniotic Fluid/microbiology , Premature Birth/genetics , Premature Birth/immunology , Premature Birth/metabolism , Obstetric Labor, Premature/genetics , Obstetric Labor, Premature/immunology , Obstetric Labor, Premature/metabolism , Gene Components , Polymorphism, Genetic
7.
Rev. odontol. Univ. Cid. Sao Paulo ; 16(1): 55-61, jan.-abr. 2004.
Article in Portuguese | LILACS, BBO - Dentistry | ID: biblio-873098

ABSTRACT

Sendo o peso da criança, ao nascer, o determinante mais importante das chances que o recém-nascido tem de sobreviver, crescer e se desenvolver saudavelmente, a prevenção do parto prematuro toma-se um importante fator de saúde pública. Evidências apontam que as infecções crônicas podem ter um papel fundamental no estabelecimento do trabalho de parto prematuro. A doença periodontal é uma reação imuno-inflamatória decorrente de uma infecção crônica causada por microrganismos gram-positivos e gram-negativos. Ela é capaz de elevar os níveis séricos de mediadores inflamatórios que, em conjunto com bacteremias e endotoxinemias transitórias, poderiam afetar o período gestacional. Assim, vários estudos têm sido dirigidos a fim de verificar o possível papel da doença periodontal como fator de risco ao parto prematuro de neonatos de baixo peso. Este artigo vem mostrar, através de uma revisão analítica da literatura, a associação entre infecção e trabalho de parto prematuro e as evidências encontradas sobre uma possível relação causal entre doença periodontal e nascimento prematuro de baixo peso. Concluiu-se que a doença periodontal é capaz de aumentar os níveis de mediadores inflamatórios associados ao trabalho de parto; que maiores níveis de periodontopatógenos podem estar relacionados ao nascimento prematuro de baixo peso; que o tratamento da doença periodontal nas mulheres grávidas, no início da gestação, parece diminuir o risco de ocorrência de nascimento prematuro de baixo peso; quanto maior a severidade da doença periodontal, maiores são as chances de NPBP


Subject(s)
Infant, Low Birth Weight , Periodontal Diseases , Periodontitis/immunology , Periodontitis/microbiology , Obstetric Labor, Premature/immunology , Obstetric Labor, Premature/microbiology
SELECTION OF CITATIONS
SEARCH DETAIL